Incyte shares rose Thursday after the drugmaker named Bill Meury its new CEO, effective immediately, to replace the retiring Hervé Hoppenot.

Incyte has hired veteran biotech executive Bill Meury to succeed Herve Hoppenot at the helm of the biopharmaceutical company.

Larry Fink (left), CEO of BlackRock, and Stephen Schwarzman, CEO of Blackstone, on Park Avenue in New York on Wednesday, March 5, 2025. (Photograph by Aaron Richter) Financials. Cover; ...